Wednesday, July 20, 2016

CGM Monitor, HbA1c Assay Set for FDA Advisory Review

(MedPage Today) -- Panel decisions could mean "groundbreaking change" for diabetes treatment
via CGM Monitor, HbA1c Assay Set for FDA Advisory Review
by

No comments:

Post a Comment